Your browser doesn't support javascript.
loading
Single cell atlas identifies lipid-processing and immunomodulatory endothelial cells in healthy and malignant breast.
Geldhof, Vincent; de Rooij, Laura P M H; Sokol, Liliana; Amersfoort, Jacob; De Schepper, Maxim; Rohlenova, Katerina; Hoste, Griet; Vanderstichele, Adriaan; Delsupehe, Anne-Marie; Isnaldi, Edoardo; Dai, Naima; Taverna, Federico; Khan, Shawez; Truong, Anh-Co K; Teuwen, Laure-Anne; Richard, François; Treps, Lucas; Smeets, Ann; Nevelsteen, Ines; Weynand, Birgit; Vinckier, Stefan; Schoonjans, Luc; Kalucka, Joanna; Desmedt, Christine; Neven, Patrick; Mazzone, Massimiliano; Floris, Giuseppe; Punie, Kevin; Dewerchin, Mieke; Eelen, Guy; Wildiers, Hans; Li, Xuri; Luo, Yonglun; Carmeliet, Peter.
Afiliação
  • Geldhof V; Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology (CCB), VIB, Department of Oncology, Leuven Cancer Institute (LKI), KU Leuven, Leuven, 3000, Belgium.
  • de Rooij LPMH; Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology (CCB), VIB, Department of Oncology, Leuven Cancer Institute (LKI), KU Leuven, Leuven, 3000, Belgium.
  • Sokol L; Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology (CCB), VIB, Department of Oncology, Leuven Cancer Institute (LKI), KU Leuven, Leuven, 3000, Belgium.
  • Amersfoort J; Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology (CCB), VIB, Department of Oncology, Leuven Cancer Institute (LKI), KU Leuven, Leuven, 3000, Belgium.
  • De Schepper M; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Rohlenova K; Department of Pathology, University Hospitals Leuven, Leuven, Belgium.
  • Hoste G; Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology (CCB), VIB, Department of Oncology, Leuven Cancer Institute (LKI), KU Leuven, Leuven, 3000, Belgium.
  • Vanderstichele A; Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Prague-West, Czech Republic.
  • Delsupehe AM; Department of General Medical Oncology and Multidisciplinary Breast Centre, University Hospitals Leuven, Leuven, Belgium.
  • Isnaldi E; Department of Gynaecologic Oncology, Leuven Cancer Institute, University Hospital Leuven, KU Leuven, Leuven, Belgium.
  • Dai N; Department of General Medical Oncology and Multidisciplinary Breast Centre, University Hospitals Leuven, Leuven, Belgium.
  • Taverna F; Department of Gynaecologic Oncology, Leuven Cancer Institute, University Hospital Leuven, KU Leuven, Leuven, Belgium.
  • Khan S; Department of Pathology, University Hospitals Leuven, Leuven, Belgium.
  • Truong AK; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Teuwen LA; Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology (CCB), VIB, Department of Oncology, Leuven Cancer Institute (LKI), KU Leuven, Leuven, 3000, Belgium.
  • Richard F; Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology (CCB), VIB, Department of Oncology, Leuven Cancer Institute (LKI), KU Leuven, Leuven, 3000, Belgium.
  • Treps L; Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology (CCB), VIB, Department of Oncology, Leuven Cancer Institute (LKI), KU Leuven, Leuven, 3000, Belgium.
  • Smeets A; National Center for Cancer Immune Therapy, Department of Oncology, University of Copenhagen, Herlev, Denmark.
  • Nevelsteen I; Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology (CCB), VIB, Department of Oncology, Leuven Cancer Institute (LKI), KU Leuven, Leuven, 3000, Belgium.
  • Weynand B; Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology (CCB), VIB, Department of Oncology, Leuven Cancer Institute (LKI), KU Leuven, Leuven, 3000, Belgium.
  • Vinckier S; Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium and Center for Oncological Research, University of Antwerp, Antwerp, Belgium.
  • Schoonjans L; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Kalucka J; Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology (CCB), VIB, Department of Oncology, Leuven Cancer Institute (LKI), KU Leuven, Leuven, 3000, Belgium.
  • Desmedt C; Multidisciplinary Breast Centre and Department of Surgical Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
  • Neven P; Multidisciplinary Breast Centre and Department of Surgical Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
  • Mazzone M; Department of Pathology, University Hospitals Leuven, Leuven, Belgium.
  • Floris G; Laboratory of Translational Cell & Tissue Research, Department of Imaging and Pathology, KU Leuven, Leuven, 3000, Belgium.
  • Punie K; Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology (CCB), VIB, Department of Oncology, Leuven Cancer Institute (LKI), KU Leuven, Leuven, 3000, Belgium.
  • Dewerchin M; Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology (CCB), VIB, Department of Oncology, Leuven Cancer Institute (LKI), KU Leuven, Leuven, 3000, Belgium.
  • Eelen G; State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, 510275, Guangzhou, Guangdong, People's Republic of China.
  • Wildiers H; Aarhus University of Advanced Studies (AIAS), Aarhus University, Aarhus, 8000, Denmark.
  • Li X; Department of Biomedicine, Aarhus University, Aarhus, 8000, Denmark.
  • Luo Y; Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, 8000, Denmark.
  • Carmeliet P; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.
Nat Commun ; 13(1): 5511, 2022 09 20.
Article em En | MEDLINE | ID: mdl-36127427
ABSTRACT
Since a detailed inventory of endothelial cell (EC) heterogeneity in breast cancer (BC) is lacking, here we perform single cell RNA-sequencing of 26,515 cells (including 8433 ECs) from 9 BC patients and compare them to published EC taxonomies from lung tumors. Angiogenic ECs are phenotypically similar, while other EC subtypes are different. Predictive interactome analysis reveals known but also previously unreported receptor-ligand interactions between ECs and immune cells, suggesting an involvement of breast EC subtypes in immune responses. We also identify a capillary EC subtype (LIPEC (Lipid Processing EC)), which expresses genes involved in lipid processing that are regulated by PPAR-γ and is more abundant in peri-tumoral breast tissue. Retrospective analysis of 4648 BC patients reveals that treatment with metformin (an indirect PPAR-γ signaling activator) provides long-lasting clinical benefit and is positively associated with LIPEC abundance. Our findings warrant further exploration of this LIPEC/PPAR-γ link for BC treatment.
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Metformina Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Nat Commun Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Metformina Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Nat Commun Ano de publicação: 2022 Tipo de documento: Article